JP2020505400A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020505400A5 JP2020505400A5 JP2019540094A JP2019540094A JP2020505400A5 JP 2020505400 A5 JP2020505400 A5 JP 2020505400A5 JP 2019540094 A JP2019540094 A JP 2019540094A JP 2019540094 A JP2019540094 A JP 2019540094A JP 2020505400 A5 JP2020505400 A5 JP 2020505400A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- alkyl
- replaced
- optionally
- heterocyclyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229910052739 hydrogen Inorganic materials 0.000 claims 23
- 229910052731 fluorine Inorganic materials 0.000 claims 17
- 125000001072 heteroaryl group Chemical group 0.000 claims 16
- 229910052801 chlorine Inorganic materials 0.000 claims 14
- -1 NC- Chemical group 0.000 claims 10
- 150000001875 compounds Chemical class 0.000 claims 10
- 125000000623 heterocyclic group Chemical group 0.000 claims 10
- 150000003839 salts Chemical class 0.000 claims 10
- 229910052799 carbon Inorganic materials 0.000 claims 9
- 125000000217 alkyl group Chemical group 0.000 claims 7
- 125000001153 fluoro group Chemical group F* 0.000 claims 6
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 claims 6
- 125000000753 cycloalkyl group Chemical group 0.000 claims 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 4
- 125000004632 tetrahydrothiopyranyl group Chemical group S1C(CCCC1)* 0.000 claims 4
- 125000003831 tetrazolyl group Chemical group 0.000 claims 4
- 125000006704 (C5-C6) cycloalkyl group Chemical group 0.000 claims 3
- 125000005842 heteroatom Chemical group 0.000 claims 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 2
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 2
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 2
- 125000001715 oxadiazolyl group Chemical group 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 125000003226 pyrazolyl group Chemical group 0.000 claims 2
- 125000004076 pyridyl group Chemical group 0.000 claims 2
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 2
- 125000001424 substituent group Chemical group 0.000 claims 2
- 125000001412 tetrahydropyranyl group Chemical group 0.000 claims 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 2
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 1
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 1
- 208000024172 Cardiovascular disease Diseases 0.000 claims 1
- 208000032928 Dyslipidaemia Diseases 0.000 claims 1
- 206010022489 Insulin Resistance Diseases 0.000 claims 1
- 208000017170 Lipid metabolism disease Diseases 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17153384.7 | 2017-01-26 | ||
| EP17153384 | 2017-01-26 | ||
| PCT/EP2018/051384 WO2018138027A1 (en) | 2017-01-26 | 2018-01-22 | Benzylaminopyridylcyclopropanecarboxylic acids, pharmaceuticalcompositions and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020505400A JP2020505400A (ja) | 2020-02-20 |
| JP2020505400A5 true JP2020505400A5 (enExample) | 2021-01-14 |
| JP7023969B2 JP7023969B2 (ja) | 2022-02-22 |
Family
ID=57906576
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019540094A Active JP7023969B2 (ja) | 2017-01-26 | 2018-01-22 | ベンジルアミノピリジルシクロプロパンカルボン酸、その医薬組成物及び使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US10919859B2 (enExample) |
| EP (1) | EP3573952B1 (enExample) |
| JP (1) | JP7023969B2 (enExample) |
| CN (1) | CN110177773B (enExample) |
| WO (1) | WO2018138027A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6968181B2 (ja) * | 2017-01-26 | 2021-11-17 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | インダニルアミノピラジニルシクロプロパンカルボン酸、その医薬組成物及び使用 |
| US10793530B2 (en) * | 2017-01-26 | 2020-10-06 | Boehringer Ingelheim International Gmbh | Benzylaminopyrazinylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof |
| CN110312714B (zh) * | 2017-01-26 | 2022-12-09 | 勃林格殷格翰国际有限公司 | 苄基氧基吡嗪基环丙烷甲酸、其药物组合物和用途 |
| US10913720B2 (en) * | 2017-01-26 | 2021-02-09 | Boehringer Ingelheim International Gmbh | Benzyloxypyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof |
| WO2019160882A1 (en) | 2018-02-13 | 2019-08-22 | Gilead Sciences, Inc. | Pd-1/pd-l1 inhibitors |
| WO2019204609A1 (en) | 2018-04-19 | 2019-10-24 | Gilead Sciences, Inc. | Pd-1/pd-l1 inhibitors |
| BR112020026746A2 (pt) | 2018-07-13 | 2021-03-30 | Gilead Sciences, Inc. | Composto, composição farmacêutica, métodos para inibir pd-1, pd-l1 e/ou a interação de pd-1/pd-l1 e para tratar câncer, e, kit para tratar ou prevenir câncer ou uma doença ou condição. |
| CN112955435B (zh) | 2018-10-24 | 2024-09-06 | 吉利德科学公司 | Pd-1/pd-l1抑制剂 |
| JP2022552655A (ja) | 2019-10-07 | 2022-12-19 | キャリーオペ，インク． | Ｇｐｒ１１９アゴニスト |
| PH12022552277A1 (en) | 2020-02-28 | 2024-03-04 | Kallyope Inc | Gpr40 agonists |
| JP2023526625A (ja) | 2020-05-19 | 2023-06-22 | キャリーオペ，インク． | Ａｍｐｋアクチベーター |
| CN116390925A (zh) | 2020-06-26 | 2023-07-04 | 卡尔优普公司 | Ampk活化剂 |
Family Cites Families (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US628476A (en) | 1898-03-18 | 1899-07-11 | Joseph Howard Kirk | Junction of cycle, motor-car, or other frames, &c. |
| US2505322A (en) | 1945-09-14 | 1950-04-25 | Gibson Refrigerator Co | Refrigerator cabinet |
| US2560111A (en) | 1946-11-07 | 1951-07-10 | Raymond T Levine | Buffing chuck |
| US2656003A (en) | 1948-02-27 | 1953-10-20 | Inst Of Inventive Res | High explosive disk-shaped charge for seismic exploration |
| US2727340A (en) | 1953-08-31 | 1955-12-20 | Alfred S Zanotta | Portable tool for reconditioning crane rails |
| US5356287A (en) | 1987-03-16 | 1994-10-18 | Mcintyre Kevin M | Simulating presence |
| AU2003277576A1 (en) | 2002-11-08 | 2004-06-07 | Takeda Pharmaceutical Company Limited | Receptor function controlling agent |
| US7135575B2 (en) | 2003-03-03 | 2006-11-14 | Array Biopharma, Inc. | P38 inhibitors and methods of use thereof |
| EP1630152A4 (en) | 2003-05-30 | 2009-09-23 | Takeda Pharmaceutical | CONDENSED CYCLIC COMPOUND |
| WO2005051890A1 (en) | 2003-11-19 | 2005-06-09 | Smithkline Beecham Corporation | Aminophenylcyclopropyl carboxylic acids and derivatives as agonists to gpr40 |
| EP1726580A4 (en) * | 2004-03-15 | 2008-02-13 | Takeda Pharmaceutical | AMINOPHNYLPROPANO ACID DERIVATIVE |
| DE102004017930A1 (de) | 2004-04-14 | 2005-11-03 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel |
| TW200640863A (en) | 2005-02-15 | 2006-12-01 | Glaxo Group Ltd | Compounds which potentiate glutamate receptor and uses thereof in medicine |
| EP1866278A1 (en) | 2005-03-28 | 2007-12-19 | Pfizer, Inc. | Substituted aryloxoethyl cyclopropanecarboxamide compounds as vr1 receptor antagonists |
| US7664629B2 (en) | 2005-07-19 | 2010-02-16 | Xerox Corporation | Second language writing advisor |
| JP5084503B2 (ja) * | 2005-07-29 | 2012-11-28 | 武田薬品工業株式会社 | シクロプロパンカルボン酸化合物 |
| WO2007033002A1 (en) | 2005-09-14 | 2007-03-22 | Amgen Inc. | Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders |
| JP2009530237A (ja) | 2006-03-15 | 2009-08-27 | ノイロサーチ アクティーゼルスカブ | キナゾリノン及びカリウムチャネル活性化剤としてのその使用 |
| JPWO2007114213A1 (ja) | 2006-03-30 | 2009-08-13 | 旭化成ファーマ株式会社 | 置換二環式環状誘導体及びその用途 |
| ES2379661T3 (es) | 2006-06-27 | 2012-04-30 | Takeda Pharmaceutical Company Limited | Compuestos cíclicos condensados |
| TW200838526A (en) * | 2006-12-01 | 2008-10-01 | Astellas Pharma Inc | Carboxylic acid derivatives |
| JP2011016722A (ja) * | 2007-10-23 | 2011-01-27 | Astellas Pharma Inc | チアゾリジンジオン化合物 |
| MX2010014571A (es) * | 2008-06-25 | 2011-03-25 | Daiichi Sankyo Co Ltd | Compuestos de acido carboxilico. |
| ES2345916B1 (es) | 2008-10-14 | 2011-09-14 | Clipdorfix, S.L. | Dispositivo de fijacion liberable de elementos adosados. |
| JP5551707B2 (ja) | 2008-10-15 | 2014-07-16 | アムジエン・インコーポレーテツド | スピロ環ｇｐｒ４０調節因子 |
| US20110269783A1 (en) | 2008-11-10 | 2011-11-03 | Neurosearch A/S | Novel 2,3-diamino-quinazolinone derivatives and their medical use |
| US20120172351A1 (en) | 2009-06-09 | 2012-07-05 | Nobuyuki Negoro | Novel fused cyclic compound and use thereof |
| WO2011094890A1 (en) | 2010-02-02 | 2011-08-11 | Argusina Inc. | Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators |
| JP2013529210A (ja) | 2010-05-18 | 2013-07-18 | メルク・シャープ・エンド・ドーム・コーポレイション | Ｓｓｔｒ５アンタゴニストとしてのスピロイソオキサゾリン化合物 |
| TW201643169A (zh) | 2010-07-09 | 2016-12-16 | 艾伯維股份有限公司 | 作為s1p調節劑的螺-哌啶衍生物 |
| HUE025363T2 (en) | 2010-12-01 | 2016-02-29 | Boehringer Ingelheim Int | Indanyl Oxide Hydrobenzofuranylacetic Acids that can be used to treat metabolic syndrome |
| BR112013020634A2 (pt) | 2011-02-17 | 2016-10-25 | Takeda Pharmaceutical | método para produzir uma forma opticamente ativa de um composto, sal, complexo de rutênio, composto, e, cristal |
| US8642585B2 (en) | 2012-03-26 | 2014-02-04 | Boehringer Ingelheim International Gmbh | Indanyloxydihydrobenzofuranylacetic acids |
| US8633182B2 (en) | 2012-05-30 | 2014-01-21 | Boehringer Ingelheim International Gmbh | Indanyloxyphenylcyclopropanecarboxylic acids |
| CN104684907A (zh) * | 2012-08-02 | 2015-06-03 | 默沙东公司 | 抗糖尿病的三环化合物 |
| WO2014019186A1 (en) | 2012-08-02 | 2014-02-06 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
| BR112015009376A2 (pt) | 2012-11-28 | 2017-07-04 | Boehringer Ingelheim Int | ácidos indaniloxidihidrobenzofuranilacéticos |
| JP6283862B2 (ja) | 2012-12-07 | 2018-02-28 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規インダニルオキシジヒドロベンゾフラニル酢酸 |
| CA2900348C (en) | 2013-02-28 | 2021-06-22 | Sk Chemicals Co., Ltd. | Tricyclic compound and use thereof |
| CN105473595A (zh) | 2013-08-23 | 2016-04-06 | 福建海西新药创制有限公司 | 治疗糖尿病的羧酸化合物 |
| WO2015051496A1 (en) | 2013-10-08 | 2015-04-16 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
| US10538490B2 (en) * | 2016-10-25 | 2020-01-21 | Boehringer Ingelheim International Gmbh | Benzylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof |
| US10913720B2 (en) | 2017-01-26 | 2021-02-09 | Boehringer Ingelheim International Gmbh | Benzyloxypyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof |
| US10793530B2 (en) * | 2017-01-26 | 2020-10-06 | Boehringer Ingelheim International Gmbh | Benzylaminopyrazinylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof |
| CN110312714B (zh) | 2017-01-26 | 2022-12-09 | 勃林格殷格翰国际有限公司 | 苄基氧基吡嗪基环丙烷甲酸、其药物组合物和用途 |
| WO2018146008A1 (en) | 2017-02-08 | 2018-08-16 | Boehringer Ingelheim International Gmbh | Indanylaminoazadihydrobenzofuranylacetic acids, pharmaceutical compositions for the treatment of diabetes |
-
2018
- 2018-01-22 CN CN201880006856.6A patent/CN110177773B/zh active Active
- 2018-01-22 US US16/479,224 patent/US10919859B2/en active Active
- 2018-01-22 EP EP18703220.6A patent/EP3573952B1/en active Active
- 2018-01-22 JP JP2019540094A patent/JP7023969B2/ja active Active
- 2018-01-22 WO PCT/EP2018/051384 patent/WO2018138027A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020505400A5 (enExample) | ||
| JP2020505393A5 (enExample) | ||
| JP2020505402A5 (enExample) | ||
| JP2020514315A5 (enExample) | ||
| JP2020505394A5 (enExample) | ||
| JP2019535792A5 (enExample) | ||
| JP2020506205A5 (enExample) | ||
| JP2018526405A5 (enExample) | ||
| JP2018526352A5 (enExample) | ||
| JP2019532110A5 (enExample) | ||
| RU2403258C2 (ru) | Тиазолилдигидроиндазолы | |
| JP2016530259A5 (enExample) | ||
| JP2019509276A5 (enExample) | ||
| JP2013544268A5 (enExample) | ||
| JP2015504091A5 (enExample) | ||
| EP4458348A3 (en) | Pharmaceutical compositions containing substituted polycyclic pyridone derivatives and prodrug thereof | |
| RU2016137832A (ru) | Соединения для лечения опосредованных комплементом нарушений | |
| JP2019527203A5 (enExample) | ||
| JP2018522879A5 (enExample) | ||
| JP2015532295A5 (enExample) | ||
| JP2014507421A5 (enExample) | ||
| JP2014037426A5 (enExample) | ||
| JP2015501833A5 (enExample) | ||
| JP2016510323A5 (enExample) | ||
| SI2738156T1 (en) | TETRACYCLINE COMPOSITE SUBSTITUTED WITH 9-AMINOMETHYL |